ReviewZeitschrift fur Rheumatologie2026
[Immune cell populations in rheumatoid arthritis and giant cell arteritis].
Review in Zeitschrift fur Rheumatologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRheumatoid arthritis (RA) and giant cell arteritis (GCA) are systemic autoimmune diseases with distinct clinical manifestations that are driven by dysregulation of multiple cell populations of the innate and adaptive immune systems.
objectiveThe aim of this work is to describe and compare the role of central immune cell populations in RA and GCA. MATERIAL AND
methodsThis review is based on a comprehensive literature search in PubMed. Recent publications on immune cell populations in RA and GCA were assessed for their pathogenic significance and therapeutic implications.
resultsBoth diseases show complex interactions between T cells, B cells, and cells of the innate immune system. A common feature is an imbalance between pro-inflammatory and regulatory mechanisms, ultimately leading to chronic inflammation and tissue damage. Key differences include a dominant role of autoreactive lymphocytes and autoantibodies in RA, whereas dendritic cells and T cell-mediated vascular inflammation are the main drivers in GCA.
conclusionA deeper understanding of these immune cell populations enables new treatment strategies and could be particularly relevant for patients who do not adequately respond to current forms of treatment.
Indexed as
Identifiers
42412170What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.